07084280falseDentistry2024-11-012025-10-31http://www.companieshouse.gov.uk/2024-10-31http://www.companieshouse.gov.uk/pt:ShareCapital2024-10-31http://www.companieshouse.gov.uk/cd:Director12024-11-012025-10-31http://www.companieshouse.gov.uk/pt:ShareCapital2025-10-31http://www.companieshouse.gov.uk/cd:Director22024-11-012025-10-31http://www.companieshouse.gov.uk/pt:ToolsEquipment2024-10-31http://www.companieshouse.gov.uk/cd:OrdinaryShareClass12024-11-012025-10-31http://www.companieshouse.gov.uk/pt:ToolsEquipment2025-10-31http://www.companieshouse.gov.uk/cd:RegisteredOffice2024-11-012025-10-31http://www.companieshouse.gov.uk/pt:NetGoodwill2024-10-31http://www.companieshouse.gov.uk/pt:NetGoodwill2025-10-31http://www.companieshouse.gov.uk/cd:AuditExemptWithAccountantsReport2024-11-012025-10-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2025-10-31http://www.companieshouse.gov.uk/pt:NetGoodwill2024-11-012025-10-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2024-10-31http://www.companieshouse.gov.uk/2024-11-012025-10-31http://www.companieshouse.gov.uk/2024-10-31http://www.companieshouse.gov.uk/cd:FRS1022024-11-012025-10-31http://www.companieshouse.gov.uk/2025-10-31http://www.companieshouse.gov.uk/pt:LandBuildings2024-10-31http://www.companieshouse.gov.uk/cd:PrivateLimitedCompanyLtd2024-11-012025-10-31http://www.companieshouse.gov.uk/cd:FilletedAccounts2024-11-012025-10-31http://www.companieshouse.gov.uk/pt:LandBuildings2025-10-31iso4217:GBPxbrli:sharesxbrli:pure
Registered number: 07084280

OSSEO REGENERATIVE TECHNOLOGIES (UK) LTD

ACCOUNTS
FOR THE YEAR ENDED 31/10/2025

Prepared By:
Staffer Mayled & Co Ltd
46-48
Station Road
Cardiff
CF14 5LU

OSSEO REGENERATIVE TECHNOLOGIES (UK) LTD

ACCOUNTS
FOR THE YEAR ENDED 31/10/2025
DIRECTORS
Dr David Guy
Dr Hui Chen
REGISTERED OFFICE
46-48 Station Road
Llanishen
Cardiff
CF14 5LU
COMPANY DETAILS
Private company limited by shares registered in EW - England and Wales, registered number 07084280
ACCOUNTANTS
Staffer Mayled & Co Ltd
46-48
Station Road
Cardiff
CF14 5LU

OSSEO REGENERATIVE TECHNOLOGIES (UK) LTD

ACCOUNTS
FOR THEYEARENDED31/10/2025
CONTENTS
Page
Directors' Report-
Accountants' Report-
Statement Of Comprehensive Income-
Balance Sheet3
Notes To The Accounts4
The following do not form part of the statutory financial statements:
Trading And Profit And Loss Account-
Profit And Loss Account Summaries-

OSSEO REGENERATIVE TECHNOLOGIES (UK) LTD

BALANCE SHEET AT 31/10/2025
20252024
Notes££
FIXED ASSETS
Intangible assets21,637,9611,856,370
Tangible assets3910,518931,142
2,548,4792,787,512
CURRENT ASSETS
Stock3,0042,818
Debtors6100,07595,540
Cash at bank and in hand613,265950,428
716,3441,048,786
CREDITORS: Amounts falling due within one year7715,3571,062,389
NET CURRENT ASSETS / (LIABILITIES)987(13,603)
TOTAL ASSETS LESS CURRENT LIABILITIES2,549,4662,773,909
CREDITORS: Amounts falling due after more than one year81,471,6011,766,370
PROVISIONS FOR LIABILITIES AND CHARGES104,3794,792
NET ASSETS1,073,4861,002,747
CAPITAL AND RESERVES
Called up share capital11100100
Profit and loss account1,073,3861,002,647
SHAREHOLDERS' FUNDS1,073,4861,002,747
For the year ending 31/10/2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have decided not to deliver to the registrar a copy of the company's profit and loss account.
Approved by the board on 21/05/2026 and signed on their behalf by
.............................
Dr David Guy
Director

OSSEO REGENERATIVE TECHNOLOGIES (UK) LTD

NOTES TO THE ACCOUNTS
FOR THE YEAR ENDED 31/10/2025
1. ACCOUNTING POLICIES
1a. Depreciation
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives.
Land And Buildingsstraight line 2%
Equipmentreducing balance 25%
1b. Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell (net realisable value). Costs, which comprise direct production costs, are based on the method most appropriate to the type of inventory class, but usually on a first-in-first-out basis. Overheads are charged to profit or loss as incurred. Net realisable value is based on the estimated selling price less any estimated completion or selling costs.
When stocks are sold, the carrying amount of those stocks is recognised as an expense in the period in which the related revenue is recognised. The amount of any write-down of stocks to net realisable value and all losses of stocks are recognised as an expense in the period in which the write-down or loss occurs. The amount of any reversal of any write-down of stocks is recognised as a reduction in the amount of stocks recognised as an expense in the period in which the reversal occurs.
1c. Pension Costs
The company operates a defined contribution pension scheme. The pension charge represents the amounts payable by the company to the fund in respect of the year.
1d. Goodwill
Goodwill arising in connection with the acquisition of businesses is capitalised and amortised over its estimated economic life to a maximum of 10 years. Goodwill is reviewed annually for impairment if events or changes in circumstances indicate that the carrying value may not be recoverable.
1e. Investments
Fixed asset investments are shown at cost less amounts written off.
Provisions are made for permanent fluctuations in value.

OSSEO REGENERATIVE TECHNOLOGIES (UK) LTD

2. INTANGIBLE FIXED ASSETS
Purchased
GoodwillTotal
££
Cost
At 01/11/20242,184,0692,184,069
At 31/10/20252,184,0692,184,069
Depreciation
At 01/11/2024327,699327,699
For the year218,409218,409
At 31/10/2025546,108546,108
Net Book Amounts
At 31/10/20251,637,9611,637,961
At 31/10/20241,856,3701,856,370
3. TANGIBLE FIXED ASSETS
Land And
BuildingsEquipmentTotal
£££
Cost
At 01/11/20241,013,085128,3431,141,428
Additions-4,7364,736
At 31/10/20251,013,085133,0791,146,164
Depreciation
At 01/11/202497,580112,706210,286
For the year20,2655,09525,360
At 31/10/2025117,845117,801235,646
Net Book Amounts
At 31/10/2025895,24015,278910,518
At 31/10/2024915,50515,637931,142
4. FINANCIAL ASSETS
Cost
Amortisation
Net Book Amounts

OSSEO REGENERATIVE TECHNOLOGIES (UK) LTD

5. STOCK 20252024
££
Stock comprises:
Stock3,0042,818
3,0042,818
6. DEBTORS 20252024
££
Amounts falling due within one year
Other debtors10,66714,014
Amounts due from associated companies56,06154,441
Prepayments33,34727,085
100,07595,540
Amounts due from associated companies are related to balances held with Guy's College Limited, company number 11206180.
7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
20252024
££
UK corporation tax127,560291,747
PAYE control4,7723,803
Directors current account87,356185,649
Bank Loan352,021356,987
Hire purchase1,3452,347
Trade creditors117,367161,929
Accruals24,93618,456
Deferred income-41,471
715,3571,062,389

OSSEO REGENERATIVE TECHNOLOGIES (UK) LTD

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
20252024
££
Loans >1yr1,471,6011,765,160
Hire purchase >1yr-1,210
1,471,6011,766,370
On the 7/05/2020 the company received a Covid bounce back loan of £50,000. Repayments started on 07/06/2021, consisting of 60 payments of £833.33. Interest rate of 2.500% applies. On the 26/10/2020 the company entered into a loan agreement for £910,000 with 240 fixed payments of £4,760.09. Interest rate of 2.360% applies. On the 30/05/2023 the company entered into a loan agreement for £557,000 with average monthly repayment of £2,960 (variable). Interest rate of 6.530% applies. On the 31/05/2024 the company entered into repayment agreement for £1,120,000 with 48 fixed monthly interest-free repayments of £19,166. This agreement relates to purchase of additional goodwill. Client entered into a hire purchase agreement on 08/07/2021. £11,738.60 is payable over 60 monthly instalments of £195.56. This agreement relates to purchase of new assets.
9. EMPLOYEES
20252024
No.No.
Average number of employees812
10. PROVISIONS FOR LIABILITIES 20252024
££
Pensions560883
Deferred taxation3,8193,909
4,3794,792
11. SHARE CAPITAL 20252024
££
Allotted, issued and fully paid:
100 Ordinary shares of £1 each100100
100100
12. CONTROLLING PARTY
Are the directors and shareholders of the company.